Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLRMT | O00411 | 1/20 | 0.43 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.31 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18636492 | 0.92 | POLRMT (0.43) | POLRMTTMPRSS2 | |
| SCHEMBL22355478 | 0.90 | POLRMT (0.41) | POLRMTTMPRSS2 | |
| SCHEMBL19223089 | 0.86 | POLRMT (0.45) | POLRMT | |
| SCHEMBL23034577 | 0.84 | POLRMT (0.42) | POLRMT | |
| SCHEMBL20762030 | 0.84 | POLRMT (0.41) | POLRMTTMPRSS2 | |
| SCHEMBL19223072 | 0.83 | TMPRSS2 (0.39) | POLRMTTMPRSS2 | |
| SCHEMBL10120078 | 0.80 | POLRMT (0.51) | POLRMTP2RY2 | |
| SCHEMBL22143120 | 0.80 | TMPRSS2 (0.34) | POLRMTTMPRSS2 | |
| SCHEMBL24462490 | 0.78 | POLRMT (0.32) | POLRMTTMPRSS2 | |
| SCHEMBL23960380 | 0.77 | POLRMT (0.37) | POLRMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10695361-B2 | Methods for treating arenaviridae and coronaviridae virus infections | GILEAD SCIENCES, INC. (US) | 2020-06-30 | — | — | US | disclosed |
| US-20190255085-A1 | METHODS FOR TREATING ARENAVIRIDAE AND CORONAVIRIDAE VIRUS INFECTIONS | GILEAD SCIENCES, INC. | 2019-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10695361-B2 | Methods for treating arenaviridae and coronaviridae virus infections | ACE, PNP, ACE2 | POLRMT 1645/4885TMPRSS2 12/4885P2RY2 3834/4885 |
| US-20190255085-A1 | METHODS FOR TREATING ARENAVIRIDAE AND CORONAVIRIDAE VIRUS INFECTIONS | ACE, PNP, ACE2 | POLRMT 1645/4885TMPRSS2 12/4885P2RY2 3834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.